Intellia Therapeutics
Kyra Silbernagel is an experienced clinical trial manager with a strong background in clinical research and biochemistry. Currently serving as a Clinical Trial Manager at Intellia Therapeutics, Inc. since April 2022, Kyra previously held similar roles at BioAge Labs and miRagen Therapeutics, Inc., where experience was gained as both Associate and Clinical Trial Manager. Early in the career, Kyra worked at Arrowhead Pharmaceuticals as a Chemistry Intern and held customer service responsibilities at Wisconsin Aviation, Inc. Kyra earned a degree in Biochemistry along with certificates in Business and Environmental Studies from the University of Wisconsin-Madison.
This person is not in the org chart
This person is not in any offices
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.